Total Payments
$71,856
2024 Payments
$8,436
Companies
15
Transactions
195
Medicare Patients
2,709
Medicare Billing
$454,928
Payment Breakdown by Category
Other$62,976 (87.6%)
Food & Beverage$4,306 (6.0%)
Travel$3,115 (4.3%)
Consulting$831.25 (1.2%)
Education$628.15 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $62,976 | 34 | 87.6% |
| Food and Beverage | $4,306 | 140 | 6.0% |
| Travel and Lodging | $3,115 | 15 | 4.3% |
| Consulting Fee | $831.25 | 1 | 1.2% |
| Education | $628.15 | 5 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $46,492 | 90 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $9,478 | 23 | $0 (2024) |
| Abbott Laboratories | $8,957 | 34 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $3,361 | 5 | $0 (2017) |
| Intuity Medical Inc | $2,404 | 8 | $0 (2023) |
| Medtronic, Inc. | $336.31 | 9 | $0 (2024) |
| Medtronic MiniMed, Inc. | $219.80 | 8 | $0 (2019) |
| Amgen Inc. | $158.79 | 3 | $0 (2024) |
| Radius Health, Inc. | $127.51 | 4 | $0 (2019) |
| Dexcom, Inc. | $123.32 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,436 | 19 | Abbott Laboratories ($8,157) |
| 2023 | $2,731 | 16 | Intuity Medical Inc ($2,404) |
| 2022 | $119.70 | 1 | SANOFI-AVENTIS U.S. LLC ($119.70) |
| 2021 | $92.65 | 2 | SANOFI-AVENTIS U.S. LLC ($81.05) |
| 2020 | $8,988 | 17 | Novo Nordisk Inc ($8,898) |
| 2019 | $18,043 | 67 | Novo Nordisk Inc ($17,814) |
| 2018 | $29,944 | 65 | Novo Nordisk Inc ($19,779) |
| 2017 | $3,501 | 8 | AstraZeneca Pharmaceuticals LP ($3,361) |
All Payment Transactions
195 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Durable Pump | ||||||
| 11/18/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $75.63 | General |
| Category: Diabetes Care | ||||||
| 11/07/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,850.00 | General |
| Category: Diabetes Care | ||||||
| 11/07/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Travel and Lodging | In-kind items and services | $35.38 | General |
| Category: Diabetes Care | ||||||
| 11/07/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Travel and Lodging | In-kind items and services | $9.02 | General |
| Category: Diabetes Care | ||||||
| 09/26/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: Bone Health | ||||||
| 09/25/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $475.00 | General |
| Category: Diabetes Care | ||||||
| 09/16/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,850.00 | General |
| Category: Diabetes Care | ||||||
| 09/12/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: Diabetes Care | ||||||
| 09/09/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $27.47 | General |
| Category: Diabetes Care | ||||||
| 09/04/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $43.57 | General |
| Category: Durable Pump | ||||||
| 09/04/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: Durable Pump | ||||||
| 08/14/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $712.50 | General |
| Category: Diabetes Care | ||||||
| 08/09/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 06/13/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $151.86 | General |
| Category: Diabetes Care | ||||||
| 05/06/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Consulting Fee | Cash or cash equivalent | $831.25 | General |
| Category: Diabetes Care | ||||||
| 04/09/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Bone Health | ||||||
| 03/22/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: Durable Pump | ||||||
| 03/20/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: Diabetes Care | ||||||
| 12/21/2023 | Intuity Medical Inc | Pogo Automatic Blood Glucose Monitoring System (Device) | Food and Beverage | Cash or cash equivalent | $16.49 | General |
| Category: Diabetes | ||||||
| 12/18/2023 | Intuity Medical Inc | Pogo Automatic Blood Glucose Monitoring System (Device) | Food and Beverage | Cash or cash equivalent | $18.92 | General |
| Category: Diabetes | ||||||
| 12/01/2023 | Intuity Medical Inc | Pogo Automatic Blood Glucose Monitoring System (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,125.00 | General |
| Category: Diabetes | ||||||
| 12/01/2023 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Endocrinology | ||||||
| 11/20/2023 | Intuity Medical Inc | Pogo Automatic Blood Glucose Monitoring System (Device) | Food and Beverage | Cash or cash equivalent | $16.66 | General |
| Category: Diabetes | ||||||
| 11/17/2023 | Intuity Medical Inc | Pogo Automatic Blood Glucose Monitoring System (Device) | Food and Beverage | Cash or cash equivalent | $6.63 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 701 | 2,482 | $329,034 | $116,359 |
| 2022 | 10 | 705 | 2,911 | $304,231 | $121,160 |
| 2021 | 10 | 661 | 3,105 | $261,274 | $123,119 |
| 2020 | 12 | 642 | 2,751 | $246,732 | $94,290 |
Total Patients
2,709
Total Services
11,249
Medicare Billing
$454,928
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 384 | 679 | $186,725 | $63,905 | 34.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 16 | 1,320 | $66,000 | $24,235 | 36.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 46 | 56 | $19,600 | $7,147 | 36.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 50 | 51 | $12,457 | $5,449 | 43.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 35 | 68 | $8,830 | $4,412 | 50.0% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 72 | 146 | $16,060 | $4,065 | 25.3% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 39 | 76 | $5,732 | $3,013 | 52.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $6,650 | $2,406 | 36.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 19 | 21 | $3,990 | $1,235 | 31.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 21 | 46 | $2,990 | $493.08 | 16.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 357 | 659 | $155,785 | $62,145 | 39.9% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 21 | 1,680 | $69,600 | $27,966 | 40.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 54 | 120 | $15,600 | $7,069 | 45.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 59 | 62 | $14,982 | $6,830 | 45.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 33 | 38 | $11,400 | $5,659 | 49.6% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 66 | 140 | $15,080 | $3,902 | 25.9% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 52 | 115 | $9,339 | $3,604 | 38.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $5,235 | $1,920 | 36.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 18 | 22 | $3,580 | $1,455 | 40.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 28 | 58 | $3,630 | $609.04 | 16.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 345 | 627 | $122,265 | $62,659 | 51.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 24 | 1,980 | $73,500 | $32,542 | 44.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 53 | 120 | $15,605 | $7,321 | 46.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 45 | 45 | $10,767 | $5,103 | 47.4% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 52 | 105 | $8,907 | $3,407 | 38.3% |
About Dr. Daniel Rosenberg, MD
Dr. Daniel Rosenberg, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Horsham, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1790786192.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Rosenberg, MD has received a total of $71,856 in payments from pharmaceutical and medical device companies, with $8,436 received in 2024. These payments were reported across 195 transactions from 15 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($62,976).
As a Medicare-enrolled provider, Rosenberg has provided services to 2,709 Medicare beneficiaries, totaling 11,249 services with total Medicare billing of $454,928. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Horsham, PA
- Active Since 08/09/2005
- Last Updated 01/05/2024
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1790786192
Products in Payments
- Tresiba (Drug) $17,101
- Ozempic (Drug) $11,883
- SOLIQUA (Drug) $8,197
- FREESTYLE LIBRE 3 (Device) $8,186
- RYBELSUS (Drug) $5,389
- FARXIGA (Drug) $3,361
- Pogo Automatic Blood Glucose Monitoring System (Device) $2,404
- TOUJEO (Drug) $997.56
- FreeStyle Freedom Lite system (Device) $616.00
- MINIMED 780G (Device) $324.71
- Minimed 670G System (Device) $202.87
- EVENITY (Biological) $147.71
- SOLIQUA 100/33 (Biological) $128.93
- Tymlos (Biological) $127.51
- TOUJEO (Biological) $119.70
- FreeStyle Libre blood glucose Flash Monitoring System (Device) $116.59
- Omnipod (Device) $99.08
- Dexcom G6 Transmitter (Medical Supply) $48.82
- DEXCOM CGM (Device) $39.64
- FreeStyle Libre (Device) $38.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.